600062.SHG China Resources Double-Crane Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
16.09 CNY
Close of Nov 4, 2026
15.03 19.77
Market cap
CNY 16.7B
P/E
10.6x
P/B
1.34x
ROE
13.6%
Dividend yield
4.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600062.SHG undervalued?

Graham number
Price16.09
Graham value20.24
Discount20.5%

600062.SHG trades 20.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

China Resources Double-Crane Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for China Resources Double-Crane Pharmaceutical Co Ltd yet.

China Resources Double-Crane Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China…

Full company profile